LIPELLA PHARMACEUTICALS INC.
LIPO$1M
Micro CapNASDAQBiotechnology🇺🇸North America5 employees
Drugs in Pipeline
3
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
LIPO News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
LP-10 (Liposomal Tacrolimus)
Oral Lichen Planus
LP-10
Hemorrhagic Cystitis
LP-08 80mg
Interstitial Cystitis
| Drug Name | Phase | Indication | Designations |
|---|---|---|---|
LP-10 (Liposomal Tacrolimus) | Phase 2 | Oral Lichen Planus | - |
LP-10 | Phase 2 | Hemorrhagic Cystitis | - |
LP-08 80mg | Phase 2 | Interstitial Cystitis | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply